Social Media Ideas for Drug Discovery.

Molecular editing method could speed drug discovery

Scientists unveiled a reaction that swaps key carbon groups in complex compounds, offering a faster route to test new medicine candidates.

<![CDATA[Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI]]>

From Discovery to Development in Emerging Modalities

ProBio is building flexible platforms for multispecific antibodies, ADCs, and other advanced therapeutic approaches. The post From Discovery to Development in Emerging Modalities a...

<![CDATA[Evogene Announces AI-Powered Small Molecule Discovery Focused Partnership with Blavatnik Center for Drug Di...

Macrocyclic Peptide Drugs Unlocked, Membrane Permeability Screened at Scale

A new method screens large libraries of synthetic cyclic peptides to identify compounds that can enter cells for therapeutic effect, opening avenues for a modality that combines th...

Multiomics Mass Spec Workflows in Drug Discovery

Advances in end-to-end multiomics platforms and the underlying scientific knowledge now enable faster and more precise biomarker discovery, mechanistic insight generation, and ther...

The hidden innovation system behind drug repurposing 

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of research starts. The post The hidden innovation system be...

AI Predicts Gene Regulation for Drug Discovery Using Condensate Morphology

Deep learning unveils how drugs affect the dynamics of key structures within the cell. A new study maps condensate morphology to functional outcomes and sheds light on markers of h...

Growth in species discoveries fuels hopes for new drugs

Skape Bio Unlocks Generalizable GPCR Drugs Using AI Protein Design

David Baker’s latest company is making medicines for a huge protein family once deemed undruggable. A new study generated miniproteins that target GPCRs across a diversity of recep...

ZoBio Introduces DNA-Encoded Library Service for Exploratory Drug Discovery Programs

ZoBio maintains that unlike transactional DEL screening approaches that focus solely on hit generation, its platform is designed to deliver biologically relevant, structurally char...

Illuminating the Drug Development Path with Cell-Based Reporter Assays

In early discovery, researchers use high-throughput screening (HTS) to identify active compounds in a biologically relevant context. During lead characterization and validation, th...

Success Stories: Accelerating Cancer Drug Discovery

As researchers work to develop new cancer treatments, one of the biggest challenges is identifying promising drug candidates quickly and efficiently. Now, researchers at Purdue Uni...

AI Designs Miniprotein Switches for GPCR Targeting

New AI‑designed miniproteins precisely modulate GPCR signaling and reveal a new "receptor diversion" microscopy-based screening system for targeting receptors long considered diffi...

Mass Spectrometry’s Discovery Revolution

Next-generation MS platforms are transforming drug discovery by revealing complex biology earlier, faster, and at unprecedented depth. The post Mass Spectrometry’s Discovery Revolu...

Harrington Discovery Institute Uncovers Novel Drug Targets for Challenging Cancer Types

Despite remarkable progress in medical science, the prognosis for most patients diagnosed with advanced-stage cancers remains bleak. The challenge lies not only in the complexity o...

Texas A&M Researchers Develop Quantum Technique for Drug Discovery

Insider Brief It’s one thing to design a pharmaceutical drug. It’s another to know if and why it actually works. Not on paper or in a computer model. But inside the chaotic world o...

AI Can Accelerate Discovery — Development Still Decides What Advances

AI will continue changing how small molecules are discovered, but the candidates that generate the most interest in silico still have to succeed under real development conditions....

Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transfor...

Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in know...

AI Lab Partners Are Rewiring the Hunt for New Drugs

Researchers used two AI systems, Robin and Co-Scientist, to collapse the timeline from idea to drug candidate. The post AI Lab Partners Are Rewiring the Hunt for New Drugs appeared...

How human-first datasets are reshaping AI drug discovery

Discover why animal models fall short in AI drug discovery and how human-first datasets are changing that. The post How human-first datasets are reshaping AI drug discovery appeare...

Novel Therapeutic Modalities Target the Undruggable

Macrocycles, de novo antibodies, and mRNA therapies are expanding the drug discovery toolbox for unmet patient needs. The post Novel Therapeutic Modalities Target the Undruggable a...

Medra Launches Reasoning Layer for Drug Discovery Robotics

The physical AI system, named AI Experimentalist, translates research goals from natural language into executable workflows that span the entire experimental cycle, from literature...

Discovery Paves Way for Drug Therapies for Hypopigmentation Conditions

Ampyrone—an NSAID-related compound—has emerged as a promising way to enhance melanin production in human skin, according to a preclinical study led by Weill Cornell Medicine and Na...